Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes. The company needs some meaningful press releases. Pharma has been expected for over a year now. Hayward stacked the deck with people from Pharma industry on the committee the Miglani on staff for going on a year now. The there was the marking of 5 million lbs synthetics " with much more to come " per Hayward.
No news on DOD expected since August.
I can see investors getting worn weary.
Good morning. Yes , very interesting trading.
I agree with your point about Hayward and retail investors. There are too little updates given. Other companies do update on a regular basis.
Based on what I have experienced first hand in my business, large investors do, somehow, get better information than the little guy. Some things never change.
I would imagine the new administration would go after counterfeiting. It does soar a lot of jobs and in the case of the DOD, a high fail rate. He did hang everything on more jobs. I know that a fabricator using components from several sources is likely to swap out for some cheaper components to fluff up the bottom line. That's the only plausible reason they don't want a mandate to comply.
We will soon see if we are dealing with substance or rhetoric when things switch over
Good morning. Yes , very interesting trading.
I agree with your point about Hayward and retail investors. There are too little updates given. Other companies do update on a regular basis.
Based on what I have experienced first hand in my business, large investors do, somehow, get better information than the little guy. Some things never change.
I would imagine the new administration would go after counterfeiting. It does soar a lot of jobs and in the case of the DOD, a high fail rate. He did hang everything on more jobs. I know that a fabricator using components from several sources is likely to swap out for some cheaper components to fluff up the bottom line. That's the only plausible reason they don't want a mandate to comply.
We will soon see if we are dealing with substance or rhetoric when things switch over
You really do have to do better than that.
Vanguard, Fidelity, BNY Mellon are top tier funds. They all own APDN.
Warren Buffet is heavily invested in Vanguard and he rates it the best fund.
Icahn is a corporate raider. APDN does not meet his takeover model.
Souros is in Liechtenstein doing whatever.
Besides just rehashing the same old doom and gloom , there is some positive news on the retail sector.
CBS just reported the main problem with designer goods bought from online sources. Apparently Ali Baba and to some extent Amazon have made some disturbing comments about counterfeits. Apparently they are not concerned about them. Alibaba's CEO stated that the counterfeiters produce high quality and he intends to keep selling them.
APDNs collaboration with major retailers can lead to a guarantee marking of legitimate products.
This has opened up a door for APDN much greater than cotton or DLA.
Alibaba has knockoff Louis Vuitton that looks pretty good.
Blockchain
Is a database system that links orders. It marks orders and follows them through a chain presumably from production to delivery.
It can't and will not do much to stop counterfeiting. Bitcoin is using it as it can trace computer based data effectively.
Pharmaceuticals can more easily see who ordered and received their product.
But, smaller and local distribution centers would have to pay for and implement blickchain.
Same problem APDN has had at DLA.
Blockchain data is secure from tampering, however, it is not secure from duplication.
You get what you pay for
Ha!! That's the best laugh so far this year. Someone wanted to spend over $400,000 today to keep the share price at $2. I guess they wanted to spend millions over the last 2 weeks to do the same???
That's the funniest post ever. Of course, there may just be some investors with a lot of money and inside information who want to own it at this level.
Since this company only has 600 shareholders, I bet it's just a very few of them buying shares right now.
I don't personally know anyone who is buying at any level after the last year's financials
McSharhey, this is purely hypothetical.
What if Hayward has figured out or had advice about this?
If you assume that APDN and its patents represent a sure solution to securing the entire pharmacy industry, or if you only suspect it might be true....and, this is all hypothetical, then why wouldn't you buy the cure?
If you think the same is true for 3D parts, then the same would be true. Same goes for cotton and synthetics.
Conversely, or inside the APDN management. Would you want options instead of cash?
If I were a key employee of APDN, I would want to be paid and not receive options......knowing what I know as a retail investor.
I don't see any monetary reason to receive options at current market value, unless I knew a hell of a lot more.
Deductive reasoning is sometimes the only way to make a good guess. But, what do I know?
Excessive stock options can serve as a poison pill.
Not saying this is Hayward's intent, but the effect is still the same.
Options not getting timely exercised often relate to previous employees/ and or relationships.
If employees/ officers hold enough of them, they can be a potent force.
I always look at them ( and some of my stocks have a crap load of them) as a sort of potential shot across the bough.
None of this benefits retail investors. It just serves to preserve the status Quo.
The options have a cost to the holder. They have to pay the strike price to exercise them.
Right now you can buy the warrants for fifty cents. Also, there are old options that will probably never be exercised.
I don't see what benefit these options are to Beth Jantzen, etal. You can buy shares on the open market at the same price.
The Sabby deal looks like a "reissue" of a previous over allotment.
This all looks like a bunch of nothing unless Hayward sees big things happening. Based on last year's dismal quarterlies and year end, an ordinary retail investor wouldn't get whatever Hayward is doing. Hayward is CEO and Chairman of the BOD. All of this is his orchestration.
If Hayward and the employees think this is a bonus.....then why???
I can tell you one thing.
I sure wouldn't want options for a Christmas bonus.
Last year they were issued at around $3 strike price.
Assuming this is some kind of bonus, it is worth zero right now.
I notice on the schedule that a lot of the old ones are expiring and did not get exercised.
If they are some kind of benefit to Beth Jansen, et all, then what is this for?
The company performance fye 9/30/16 would not warrant any kind of bonuses.
So, I don't have a clue what it's for (contractural??).
Right then , let's just stick to facts.
1) APDN is a viable company with major customers and a stream of established revenues.
2) Deferred Sales refer to sales under contract, but unearned as of the date of the financial statement.
3) the private placement with Sabby is unknown as to its intent. Some of us are just speculating on this.
4) it appears (to me) that the Sabby deal was not needed for pipe financing. This is based on 9/30/2016 balances in cash and AR.
5) comparison of the most recent report and the prior quarter report is essential to understanding cash flow. The two quarters Cash Flow statements should also be compared to understand the liquidity of any entity.
6) all corporations have huge Authorized Shares balances. APDN is not unusual in this.
7) the Short Interest has barely wavered in 14 months. In fact it increased as of the last report.
8) Hayward is not a good person for PR. We need someone who can handle important questions during live call in sessions.
9) the 4 quarters of fye 9/30/2016 were disastrous when compared to the prior year.
10) the reason for the sales decline appears to be DLA recvenue and a change in reporting revenues from cotton tagging.
11) people who cannot perform basic financial statement analysis, should not buy stocks.
12) ranting and repeating the same thing in hundreds of posts, is a waste of everyone's time.
13) Any investment is a bit like gambling. We all rely on the performance of the company, and we expect meaningful PRs and updates. If the officers and key people are overpaid/compensated for the results, we need to know what they plan to do in the near future to warrant such. Compensation.
14) Do not invest amounts in the stock market if you can't take the bumps and hits. That's just a gambling addiction you can't afford
Just callin a spade a spade. Nothing offensive about the truth
Brain Blight
I never sent u a private message. Unless I hit the wrong button by mistake.
Don't go mental on us.
Take it slow and easy
The Sabby buy in was a giveaway for what I believe is a future deal. It really spooked the retail investors.
There are always pre-deals in the M&A world and this one looks like compensation for future fees.
I can't imagine a major drug company or synthetics manufacturer paying tens of millions to secure their supply line. Which APDN can do. No problem.
But if you were cfo of one of those companies, would you recommend paying APDN for this service or would you just gobble up the technology in a buyout?
It's the old lease or buy.
And yes, we are just playing with our own money.
I think Hayward commented in the Q&A that he can't talk about some things in the works. That type of comment, in my experience runs deep
Sorry Speed of Blight
You need to quit looking at little quip definitions of Deferred Revenue on the internet.
There is far more to it than that.
Receivables at 6/30/16 was 3.9 million. Receivables at 9/30/16 were 6.375 million.
Get it?
The AR increased much more than the sales reported.
Therefore, the huge increase in deferred revenues is reflected in receivables. Not cash.
Cash was not received for the deferred revenues and there is no liability in APDNs case.
You have to compare the last 2 quarters and analyze the. Ash flows statement to understand this.
I understand this is beyond your scope of ability.
So please do not even get into options and dilution.
I suspect the options will never be exercised prior to expiration. I am trusting your prior posts stating that Apdn is a useless microcap and will therefore never have a pps warranting the exercise of options.
Capice?
Speed of Blight
You obviously do not understand double entry bookkeeping.
AR was debited, and deferred revenue was credited.
No cash received, and no sales reported. It's a simple bookkeeping entry.
When the cash is received, a debit to Cash with offsetting credit to AR.
This then requires another entry for cash received: a debit to deferred revenue and offsetting credit to revenue.
This is basic accounting. Deferred revenue is not a liability, it is a simple booking entry to recognize revenue later when the Gin ships, rather than when APDN ships the juice.
I prepare audited statements for listed companies. Been doing it fo 40 years.
You have a basic inability to understand financials.
Do not invest in any stock without seeking counsel.
In fact there is $2,733,588 in deferred revenue at year end. Expect about 2 million to be recognized as income in the first Q.
Deferred revenue has historically been very small on APDN balance sheets.
Apparently, this recognition of tagging revenue has change to "as used" rather than as shipped
What you don't know anything about is financial statements.
You have continually stated that all of the receivables have been reported as income.
Not true.
You really have to examine the entire balance sheet before you start flapping your non stop mouth muscles.
Deferred revenue is listed there, both short and long term.
This means that part of AR has not been reported on the income statements